News icon  PreviPharma News

PreviPharma Announces Research Collaboration with Global Biotherapeutics Leader CSL Behring

September 23rd, 2019

PreviPharma today announces the start of a research collaboration with global biotherapeutics leader CSL Behring to develop a novel plasma protein-based drug for severely ill patients suffering from diseases with unmet medical needs.


PreviPharma opens new ‘Innovation Hub’ R&D facility in Mannheim

August, 2019

To achieve the next level in the development of innovative, plasma protein-based drugs for unmet medical need as well as meeting constantly growing customer demand, PreviPharma extended their present lab and office facilities opening the new Innovation Hub on the University Hospital of Mannheim (UMM) campus.